Financials
- Market Capitalization 37.81 M
- Employee 12
- Founded 2001
- CEO Joel Latham
- Website www.incannex.com.au
- Headquarter Delaware, United States
- FIGI BBG01J0814Y2
- Industry 医薬品メーカー(特殊・ジェネリック)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.16
売上高対価格比率
86.42
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4271 | INCR Intercure Ltd. - ordinary shares | 1.00 USD | +5.26% | +5.26% | +11.11% | -35.48% | 54.68 M USD | ||
| 4315 | SCYX SCYNEXIS, Inc. - Common Stock | 4.89 USD | +9.15% | +5.16% | +15.06% | +503.70% | 48.56 M USD | ||
| 4458 | ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 0.73 USD | +2.82% | -5.19% | -2.67% | -70.08% | 34.60 M USD | ||
| 4548 | CPHI China Pharma Holdings, Inc. Common Stock | 0.61 USD | +1.67% | -10.29% | -22.78% | -7.73% | 24.72 M USD |